These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 25134788)

  • 1. Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently.
    Beilfuss A; Sowa JP; Sydor S; Beste M; Bechmann LP; Schlattjan M; Syn WK; Wedemeyer I; Mathé Z; Jochum C; Gerken G; Gieseler RK; Canbay A
    Gut; 2015 May; 64(5):791-9. PubMed ID: 25134788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose vitamin D supplementation and liver histology in NASH.
    Kitson MT; Pham A; Gordon A; Kemp W; Roberts SK
    Gut; 2016 Apr; 65(4):717-8. PubMed ID: 26294696
    [No Abstract]   [Full Text] [Related]  

  • 3. Vitamin D and liver fibrosis: let's start soon before it's too late.
    Nobili V; Reif S
    Gut; 2015 May; 64(5):698-9. PubMed ID: 25192564
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitamin D Level and Vitamin D Receptor Genetic Variation Were Involved in the Risk of Non-Alcoholic Fatty Liver Disease: A Case-Control Study.
    Zhang R; Wang M; Wang M; Zhang L; Ding Y; Tang Z; Fu Z; Fan H; Zhang W; Wang J
    Front Endocrinol (Lausanne); 2021; 12():648844. PubMed ID: 34421816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor regulates TGF-β signalling in systemic sclerosis.
    Zerr P; Vollath S; Palumbo-Zerr K; Tomcik M; Huang J; Distler A; Beyer C; Dees C; Gela K; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2015 Mar; 74(3):e20. PubMed ID: 24448349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GDF11 induces mild hepatic fibrosis independent of metabolic health.
    Frohlich J; Kovacovicova K; Mazza T; Emma MR; Cabibi D; Foti M; Sobolewski C; Oben JA; Peyrou M; Villarroya F; Soresi M; Rezzani R; Cervello M; Bonomini F; Alisi A; Vinciguerra M
    Aging (Albany NY); 2020 Oct; 12(20):20024-20046. PubMed ID: 33126224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.
    Zhang H; Shen Z; Lin Y; Zhang J; Zhang Y; Liu P; Zeng H; Yu M; Chen X; Ning L; Mao X; Cen L; Yu C; Xu C
    J Biol Chem; 2020 Mar; 295(12):3891-3905. PubMed ID: 32051143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats.
    Abramovitch S; Dahan-Bachar L; Sharvit E; Weisman Y; Ben Tov A; Brazowski E; Reif S
    Gut; 2011 Dec; 60(12):1728-37. PubMed ID: 21816960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
    Ceccarelli S; Panera N; Mina M; Gnani D; De Stefanis C; Crudele A; Rychlicki C; Petrini S; Bruscalupi G; Agostinelli L; Stronati L; Cucchiara S; Musso G; Furlanello C; Svegliati-Baroni G; Nobili V; Alisi A
    Oncotarget; 2015 Dec; 6(39):41434-52. PubMed ID: 26573228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin Type III Domain-Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Petta S; Valenti L; Svegliati-Baroni G; Ruscica M; Pipitone RM; Dongiovanni P; Rychlicki C; Ferri N; Cammà C; Fracanzani AL; Pierantonelli I; Di Marco V; Meroni M; Giordano D; Grimaudo S; Maggioni M; Cabibi D; Fargion S; Craxì A
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2660-2669. PubMed ID: 28472477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imbalanced insulin substrate-1 and insulin substrate-2 signaling trigger hepatic steatosis in vitamin D deficient rats: 8-methoxypsoralen, a vitamin D receptor ligand with a promising anti-steatotic action.
    Elhafiz M; Zhao G; Ismail M; Xu D; Das D; Fan S; Cheng N; Yousef BA; Jiang Z; Zhang L
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jun; 1865(6):158657. PubMed ID: 32045698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice.
    Dong B; Zhou Y; Wang W; Scott J; Kim K; Sun Z; Guo Q; Lu Y; Gonzales NM; Wu H; Hartig SM; York RB; Yang F; Moore DD
    Hepatology; 2020 May; 71(5):1559-1574. PubMed ID: 31506976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Polymorphisms and Biological Effects of Vitamin D Receptor on Nonalcoholic Fatty Liver Disease Development and Progression.
    Tourkochristou E; Mouzaki A; Triantos C
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of vitamin D levels and vitamin D-related gene polymorphisms with liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease.
    Arai T; Atsukawa M; Tsubota A; Koeda M; Yoshida Y; Okubo T; Nakagawa A; Itokawa N; Kondo C; Nakatsuka K; Masu T; Kato K; Shimada N; Hatori T; Emoto N; Kage M; Iwakiri K
    Dig Liver Dis; 2019 Jul; 51(7):1036-1042. PubMed ID: 30683615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PNPLA3 downregulation exacerbates the fibrotic response in human hepatic stellate cells.
    Rady B; Nishio T; Dhar D; Liu X; Erion M; Kisseleva T; Brenner DA; Pocai A
    PLoS One; 2021; 16(12):e0260721. PubMed ID: 34879108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopoietin-Like Protein 8 Is a Novel Vitamin D Receptor Target Gene Involved in Nonalcoholic Fatty Liver Pathogenesis.
    García-Monzón C; Petrov PD; Rey E; Marañón P; Del Pozo-Maroto E; Guzmán C; Rodríguez de Cía J; Casado-Collado AJ; Vargas-Castrillón J; Saez A; Miquilena-Colina ME; Lo Iacono O; Castell JV; González-Rodríguez Á; Jover R
    Am J Pathol; 2018 Dec; 188(12):2800-2810. PubMed ID: 30248338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus.
    Barchetta I; Carotti S; Labbadia G; Gentilucci UV; Muda AO; Angelico F; Silecchia G; Leonetti F; Fraioli A; Picardi A; Morini S; Cavallo MG
    Hepatology; 2012 Dec; 56(6):2180-7. PubMed ID: 22753133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine induces fibrogenic changes in human liver via nicotinic acetylcholine receptors expressed on hepatic stellate cells.
    Soeda J; Morgan M; McKee C; Mouralidarane A; Lin C; Roskams T; Oben JA
    Biochem Biophys Res Commun; 2012 Jan; 417(1):17-22. PubMed ID: 22108052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathetic nervous system catecholamines and neuropeptide Y neurotransmitters are upregulated in human NAFLD and modulate the fibrogenic function of hepatic stellate cells.
    Sigala B; McKee C; Soeda J; Pazienza V; Morgan M; Lin CI; Selden C; Vander Borght S; Mazzoccoli G; Roskams T; Vinciguerra M; Oben JA
    PLoS One; 2013; 8(9):e72928. PubMed ID: 24019886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A20 Attenuates Liver Fibrosis in NAFLD and Inhibits Inflammation Responses.
    Wang X; Ai L; Xu Q; Wu C; Chen Z; Su D; Jiang X; Fan Z
    Inflammation; 2017 Jun; 40(3):840-848. PubMed ID: 28251449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.